高级搜索
鼻咽癌患者调强放疗过程中体重变化及影响因素分析[J]. 肿瘤防治研究, 2013, 40(08): 767-771. DOI: 10.3971/j.issn.1000-8578.2013.08.010
引用本文: 鼻咽癌患者调强放疗过程中体重变化及影响因素分析[J]. 肿瘤防治研究, 2013, 40(08): 767-771. DOI: 10.3971/j.issn.1000-8578.2013.08.010
Analysis of Body Weight Loss and Influence Factors During Intensity-modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(08): 767-771. DOI: 10.3971/j.issn.1000-8578.2013.08.010
Citation: Analysis of Body Weight Loss and Influence Factors During Intensity-modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(08): 767-771. DOI: 10.3971/j.issn.1000-8578.2013.08.010

鼻咽癌患者调强放疗过程中体重变化及影响因素分析

Analysis of Body Weight Loss and Influence Factors During Intensity-modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma

  • 摘要: 目的 研究鼻咽癌(nasopharyngeal carcinoma,NPC)患者调强放疗(intensity-modulated radiotherapy, IMRT)过程中的体重变化规律及影响因素。方法 回顾性分析57例鼻咽癌患者调强放疗过程中体重及身体质量指数(body mass index, BMI)变化,探讨鼻咽癌调强放疗患者体重和BMI变化规律及影响因素。结果 57例患者放疗前后平均体重分别为(60.4±9.4)kg和(55.1±8.7)kg(P=0.0025),变化范围为17 kg~-0.5 kg;放疗前后BMI分别为(22.8±3.5)kg/m2和(20.8±3.1)kg/m2P=0.0017),变化范围为6.0 kg/m2~-0.2 kg/m2。约93.0%患者调强放疗中出现不同程度体重和BMI减轻,平均体重减轻8.4%,35.1%患者体重减轻超过10.0%,68.4%体重减轻超过5.0%,体重减轻百分比范围23.4%~-0.7%。单变量多因素方差分析显示,患者性别、WHO病理分级、AJCC6th分期、身体状况评分(performance status,PS)、是否同期化疗及后程加速超分割放疗(late course accelerated hyperfractionated radiotherapy, LCAFR))对体重和BMI无明显影响(P>0.05), 而年龄≥50岁或BMI>25 kg/m2或体重>60 kg者体重减轻更明显(P<0.05)。线性回归分析每周平均放疗剂量和每周平均体重呈明显负相关(R2=-0.996,P<0.001)。结论 鼻咽癌患者调强放疗过程中体重减轻现象非常普遍,性别、WHO病理分级、AJCC6th分期、身体状况评分、是否同期化疗及后程加速超分割放疗对患者体重和BMI变化影响可能较小,而年龄、放疗前体重和BMI、放疗剂量对患者体重和BMI影响更明显。

     

    Abstract: Objective To investigate body weight loss and influence factors during intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC). Methods To explore body weight and BMI variation and influence factors,body weight and body mass index (BMI) change analysis were done retrospectively for 57 NPC patients during IMRT. Results In 57 NPC patients treated by IMRT, the pre-radiotherapy and post-radiotherapy average body weight were (60.4±9.4)kg and (55.1±8.7)kg (P=0.0025), body weight loss ranged from 17 kg to-0.5 kg,and average BMI of pre-radiotherapy and post-radiotherapy were (22.8±3.5)kg/m2,(20.8±3.1)kg/m2 (P=0.0017), ranged from 6.0 kg/m2 to -0.2 kg/m2,respectively. To the end of radiotherapy,93.0% patients lost weight at different levels, the mean percentage of weight loss was 8.4% and ranged from 23.4%to -0.7%, 35.1% patients lost weight over 10% and 68.4% patients lost weight over 5.0%. Univariate multi-factor analysis of variance showed that the WHO pathological grade, AJCC6th stage, performance status (PS), concurrent chemotherapy and late course accelerated hyperfractionated radiotherapy (LCAFR) had no statistical influence on body weight and BMI loss, but patients with age older than 50 years or BMI greater than 25 kg/m2 or body weight more than 60 kg lost body weight and BMI more than others (P<0.05). Linear regression analysis showed that average radiation dose weekly and the average body weight weekly were significantly negatively correlated (R2=-0.996,P<0.001). Conclusion Body weight loss is widespread in NPC patients during IMRT. The age, pre-radiotherapy body weight and BMI, radiation dose maybe have more impact on body weight and BMI loss significantly rather than the gender,WHO pathological grade, AJCC6thstage, performance status, concurrent chemotherapy and late course accelerated hyperfractionated radiotherapy in NPC patients with IMRT.

     

/

返回文章
返回